Nurse Practitioner in Green Lake, WI Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Mrs. Sandra Schwoerer, MSN, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 670 County Road A, Green Lake, WI 54941 Phone: 920-294-0100 Fax: 920-294-0123 |
Trina Hernandez, APNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 670 County Road A, Green Lake, WI 54941 Phone: 920-294-0100 Fax: 920-294-0123 |
News Archive
SensAble Technologies' digital dentistry product line receives $8M infusion
SensAble Technologies, Inc®, a leading provider of 3D modeling software, haptic devices and dental restoration design and fabrication solutions, announced that it has received an $8 million investment to propel sales, marketing and engineering efforts for its digital dentistry product line. Existing investor HLM Venture Partners led the round and was joined by North Bridge Venture Partners, both of whom are headquartered in the Boston area, and have extensive expertise with medical device company funding.
US-Ireland partnership awarded £2.9m to develop nanomedicine for treatment of pancreatic cancer
A US-Ireland partnership involving researchers at Queen's University Belfast has been awarded £2.9m to develop new treatments for pancreatic cancer, which is the fifth most common cause of cancer deaths in the UK.
Arana updates inflammatory pipeline milestones
Biotechnology company Arana Therapeutics Limited today provided an update on the major inflammatory compounds in its drug development pipeline. As part of this update, Arana said it has developed a new antibody candidate ART123, targeting inflammatory diseases and it plans to start a Phase I clinical trial for age-related macular degeneration (AMD) candidate PMX53 in 2009.
Protease inhibitors used to treat HIV-1 infection may also be effective for treatment or prevention of malaria
The study found protease inhibitors inhibited the growth of P. falciparum, the malaria parasite that causes most disease. These findings may also expose a previously unexplored vulnerability in the parasite that could lead to a new class of anti-malarial drug.
Protego develops sternal device for cardiac surgery with start-up investment from MRCF
Protego Medical Pty Ltd, an early stage medical technology company developing a medical device for sternal protection during cardiac surgery, was launched today with AU$2M start-up financing from Australia's Medical Research Commercialisation Fund (MRCF). At the same time, the Company announced the appointment of Pablo Solis as CEO.
› Verified 7 days ago